Why is Astrazeneca Phar falling/rising?

As of 21-Jul, Astrazeneca Pharma India Ltd's stock is currently priced at 9,128.00, reflecting an increase of 17.2 points, or 0.19%. The stock opened with a gain of 2.63% today and reached an intraday high of Rs 9,350.75. Despite this positive movement, the stock has shown a slight decline of 0.47% over the past week, while it has performed well over the longer term, with a 2.76% increase in the last month and a remarkable 24.45% rise year-to-date. The company has demonstrated strong management efficiency, evidenced by a high return on equity (ROE) of 19.06% and significant net profit growth of 88.82%. However, there are concerns regarding its long-term growth potential, as the operating profit has only grown at an annual rate of 15.95% over the last five years, and institutional investor participation has decreased.
In the broader market context, Astrazeneca Pharma's recent performance has outpaced the benchmark Sensex, which has seen a marginal decline of 0.06% over the past week. The stock's ability to outperform its sector by 0.51% today indicates strong investor interest, although the falling delivery volume suggests a potential decrease in retail investor participation. While the stock has consistently generated returns over the past three years, outperforming the BSE500, the recent decline in institutional stakes raises concerns about future growth and market confidence. Overall, the stock's current rise is supported by strong fundamentals, but the mixed signals regarding investor participation and long-term growth prospects may temper enthusiasm.